van Eyndhoven WG, Frank D, Kalachikov S, Cleary AM, Hong DI, Cho E, Nasr S, Perez AJ, Mackus WJ, Cayanis E, Wellington S, Fischer SG, Warburton D, Lederman S
A single gene for human TRAF-3 at chromosome 14q32.3 encodes a variety of mRNA species by alternative polyadenylation, mRNA splicing and transcription initiation. Mol Immunol. 1998 Dec; 35(18):1189-206.
A single gene for human TRAF-3 at chromosome 14q32.3 encodes a variety of mRNA species by alternative polyadenylation, mRNA splicing and transcription initiation.
Bunnell SC, Hong DI, Kardon JR, Yamazaki T, McGlade CJ, Barr VA, Samelson LE
T cell receptor ligation induces the formation of dynamically regulated signaling assemblies. J Cell Biol. 2002 Sep 30; 158(7):1263-75.
T cell receptor ligation induces the formation of dynamically regulated signaling assemblies.
Activation of Mast Cells Induces PKC-dependent Phosphorylation of Serine-273 of the LILRB4 Inhibitory Receptor that is Self-Regulated. AAAAI Annual Meeting, 2007. 2007.
Activation of Mast Cells Induces PKC-dependent Phosphorylation of Serine-273 of the LILRB4 Inhibitory Receptor that is Self-Regulated
Bunnell SC, Singer AL, Hong DI, Jacque BH, Jordan MS, Seminario MC, Barr VA, Koretzky GA, Samelson LE
Persistence of cooperatively stabilized signaling clusters drives T-cell activation. Mol Cell Biol. 2006 Oct; 26(19):7155-66.
Persistence of cooperatively stabilized signaling clusters drives T-cell activation.
Desensitization for Allergic Reactions to Chemotherapy. Yonsei Med J. 2019 Feb; 60(2):119-125.
Desensitization for Allergic Reactions to Chemotherapy.
Harvard T.H. Chan School of Public Health
Carlos Arturo Camargo, Jr., Dr.P.H., M.D.
Mariana Concepcion Castells, M.D., Ph.D.
Assistant Professor of Medicine, Part-time
Hong DI, Madrigal-Burgaleta R, Banerji A, Castells M, Alvarez-Cuesta E
The journal of allergy and clinical immunology. In practice
Controversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel? J Allergy Clin Immunol Pract. 2020 10; 8(9):2907-2915.e1.
Controversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel?
Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ, Breslow RG, Brockow K, Buchheit KM, Cahill KN, Cernadas J, Chiriac AM, Crestani E, Demoly P, Dewachter P, Dilley M, Farmer JR, Foer D, Fried AJ, Garon SL, Giannetti MP, Hepner DL, Hong DI, Hsu JT, Kothari PH, Kyin T, Lax T, Lee MJ, Lee-Sarwar K, Liu A, Logsdon S, Louisias M, MacGinnitie A, Maciag M, Minnicozzi S, Norton AE, Otani IM, Park M, Patil S, Phillips EJ, Picard M, Platt CD, Rachid R, Rodriguez T, Romano A, Stone CA, Torres MJ, Verdú M, Wang AL, Wickner P, Wolfson AR, Wong JT, Yee C, Zhou J, Castells M
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. J Allergy Clin Immunol Pract. 2020 10; 8(9S):S16-S116.
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs.
Tuttle KL, Stavrou E, Hong DIC, Connell NT, Wickner P
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Oxaliplatin hypersensitivity complicated by thrombocytopenia during desensitization. Ann Allergy Asthma Immunol. 2021 08; 127(2):267-269.
Oxaliplatin hypersensitivity complicated by thrombocytopenia during desensitization.
Stone CA, Robinson LB, Li L, Krantz MS, Kwah JH, Ortega G, Mancini C, Wolfson AR, Saff RR, Samarakoon U, Hong DI, Koo G, Chow TG, Gruchalla R, Liao JX, Kuster JK, Price C, Ahola C, Khan DA, Phillips EJ, Banerji A, Blumenthal KG
Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis. J Allergy Clin Immunol Pract. 2023 02; 11(2):458-465.e1.
Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis.
John Rock Professor of Climate and Population Studies
Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children. J Allergy Clin Immunol Pract. 2014 Jan-Feb; 2(1):13-9; quiz 20.
Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children.
Breslow RG, Rao JJ, Xing W, Hong DI, Barrett NA, Katz HR
Inhibition of Th2 adaptive immune responses and pulmonary inflammation by leukocyte Ig-like receptor B4 on dendritic cells. Journal of Immunology. 2010; 184(2):1003-13.
Inhibition of Th2 adaptive immune responses and pulmonary inflammation by leukocyte Ig-like receptor B4 on dendritic cells
Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, Laidlaw TM, Legere HJ, Nallamshetty SN, Palis RI, Rao JJ, Berlin ST, Campos SM, Matulonis UA
The Journal of allergy and clinical immunology
Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008 Sep; 122(3):574-80.
Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
Cheng G, Cleary AM, Ye ZS, Hong DI, Lederman S, Baltimore D
Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 1995 Mar 10; 267(5203):1494-8.
Involvement of CRAF1, a relative of TRAF, in CD40 signaling.
Hong DI, Bankova L, Cahill KN, Kyin T, Castells MC
Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies. Expert Rev Clin Immunol. 2012 Jan; 8(1):43-52; quiz 53-4.
Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies.